TAGCYX BIOTECHNOLOGIES
TagCyx’s scientific team has established its proprietary Xenoligo® technology platform, allowing high functional oligonucletide drug discovery. The Xenoligo® platform utilizes genetic alphabet expansion by unnatural base-pairs to generate customized nucleic acid suited for therapeutic applications.
TAGCYX BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Environmental Consulting
Founded:
2007-03-01
Address:
Tokyo, Tokyo, Japan
Country:
Japan
Website Url:
http://www.tagcyx.com
Total Employee:
1+
Status:
Active
Contact:
+81-3-6407-1672
Email Addresses:
[email protected]
Total Funding:
1.41 B JPY
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API WordPress Content Delivery Network Font Awesome Wordpress Plugins Nginx Microsoft Exchange Online
Similar Organizations
Nimbus Therapeutics
Nimbus Discovery is now Nimbus Therapeutics to reflect our transition into a clinical stage company.
Ocugen
Ocugen is a clinical stage biopharmaceutical company.
OncoHost
OncoHost is a clinical-stage biotechnology company developing personalized strategies to increase the success of cancer therapy.
Transcenta
Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.
Current Advisors List
Current Employees Featured
Investors List
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Venture Round - TAGCyx Biotechnologies
Healthcare Innovation
Healthcare Innovation investment in Venture Round - TAGCyx Biotechnologies
SBI Group
SBI Group investment in Venture Round - TAGCyx Biotechnologies
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Venture Round - TAGCyx Biotechnologies
UTokyo Innovation Platform
UTokyo Innovation Platform investment in Series B - TAGCyx Biotechnologies
Mizuho Capital
Mizuho Capital investment in Series B - TAGCyx Biotechnologies
SMBC Venture Capital
SMBC Venture Capital investment in Series B - TAGCyx Biotechnologies
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Series B - TAGCyx Biotechnologies
Nissay Capital
Nissay Capital investment in Venture Round - TAGCyx Biotechnologies
UTEC - The University of Tokyo Edge Capital Partners
UTEC - The University of Tokyo Edge Capital Partners investment in Venture Round - TAGCyx Biotechnologies
Official Site Inspections
http://www.tagcyx.com
- Host name: www672.sakura.ne.jp
- IP address: 59.106.19.102
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
